7% is below the median gain of 9.7%, but it's not too bad. From the FDA sheet:

"Seventy-two percent of patients treated with FORTEO achieved at least a 5% increase in spine BMD, and 44% gained 10% or more."

That's after 18 months of treatment. So, 7% after 13 months doesn't sound unreasonable.